New bipartisan legislation introduced in the House aims to reform Medicaid to enable the use of value-based purchasing agreements in Medicaid. The Medicaid VBP Act, released Tuesday, aims to ensure new treatments such as gene therapies would be administered under Medicaid via a value-based agreement that reimburses drug makers based on the outcomes the drug provides….
The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…
Value-based care models are the future of pharmaceuticals but several obstacles exist slowing the transition from volume selling to value selling. More and more, companies in this space are realizing that a traditional “pharma-first” approach is no longer enough to be successful in the future. Instead, they must evolve to adopt a more patient-centric approach designed…